July 22, 2025Frontiers in PharmacologyOpen Access

Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

HYHuiyan YangNanfang Hospital XXXiaoxiao XuTongji University MTMing TanQingdao University

Discussion

Member takes

Implication

Systematic review and network meta-analysis finds thrombopoietic agents improve outcomes in chemotherapy-induced thrombocytopenia patients, suggesting effective management options.

Key Points

Thrombopoietic agents significantly reduced platelet transfusions and improved nadir platelet count.
Eltrombopag ranked first in reducing chemotherapy dose reductions and promoting platelet recovery.
Randomized controlled trials included a total of 1,746 participants to assess various treatments.
TPO-RAs, particularly eltrombopag, show superior efficacy and tolerability for managing CIT.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/689a0614e6551bb0af8cd732 https://doi.org/10.3389/fphar.2025.1549214

View Full Paper

Ask AI

Bookmark

Implication

Systematic review and network meta-analysis finds thrombopoietic agents improve outcomes in chemotherapy-induced thrombocytopenia patients, suggesting effective management options.

Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider